InsiderClue
Insiders · Profile

Tardio Jason

President and COO at IMMUNIC · Chief Operating Officer at Ovid Therapeutics. Filing since 12 Sep 2022. CIK 0001794698

IMUX IMMUNIC, INC. President and COO · 1 trade OVID Ovid Therapeutics Inc. Chief Operating Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
IMUX IMMUNIC, INC.
5 Jun 2025
President and COO
Bought
12,512
$9.88K
opened
OVID Ovid Therapeutics Inc.
12 Sep 2022
Chief Operating Officer
Sold, plan not stated
17,344
$37.29K
100%
2 decisions on file.